Gland Pharma Ltd.

Financial

	Gland Pharma	Caplin Point Lab	Gufic Biosciences
Operational Metrics
Pharmaceutical Sector
Number of ANDA's Filed in USA	371.0 .	51.0 .	n/a
Number of ANDA's Approved By USFDA	318.0 .	38.0 .	n/a
US DMF Filings	68.0 .	n/a	n/a
Unclassified
R&D as a % of Total Sales	4.9 %	4.6 %	0.83 %
API Capacity	11000.0 Kg/Year	n/a	n/a
Financials
5 yr Average ROE	12.02 %	20.61 %	25.05 %
5yr average Equity Multiplier	1.15	1.17	2.22
5yr Average Asset Turnover Ratio	0.51	0.72	1.05
5yr Avg Net Profit Margin	20.79 %	24.8 %	10.9 %
Price to Book	3.56	5.3	6.41
P/E	46.68	28.17	55.31
5yr Avg Cash Conversion Cycle	69.81 Days	79.85 Days	26.94 Days
Inventory Days	118.26 Days	64.55 Days	66.86 Days
Days Receivable	99.92 Days	100.92 Days	128.09 Days
Days Payable	107.43 Days	74.04 Days	163.91 Days
5yr Average Interest Coverage Ratio	183.05	579.71	13.1
5yr Avg ROCE	16.55 %	25.27 %	27.25 %
5yr Avg Operating Profit Margin	29.26 %	30.87 %	18.45 %
5 yr average Debt to Equity	0.01	0.01	0.51
5yr CAGR Net Profit	-6.87 %	16.28 %	14.26 %
5yr Average Return on Assets	10.65 %	17.7 %	11.52 %
Shareholdings
Promoter Holding	51.83 %	70.56 %	72.52 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-6.04 %	1.68 %	-2.48 %
Change in Mutual Fund Holding (3 Yrs)	15.13 %	0.87 %	2.35 %

Business

	Gland Pharma	Caplin Point Lab	Gufic Biosciences
Product Wise Break-Up	Product Wise Break-Up Pharmaceutical 100.0 Injectables 0 Branded Generic 0 Generic 0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0	Product Wise Break-Up Formulations 75.0 Proton pump inhibitors 0 CMO 0 Branded Generics 25.0 Domestic 0 Muscle Relaxants 0 Pharmaceutical 0 Cardiovascular 0 Anti-bacterials 0 API 0 Anti-fungals 0 Injectables 0 International 0	Product Wise Break-Up Generic 0 Proton pump inhibitors 0 CMO 30.0 Branded Generic 0 Domestic Pharmaceuticals 50.0 Muscle Relaxants 0 Pharmaceutical 0 Cardiovascular 0 Anti-bacterials 0 Active Pharmaceutical Ingredient (API) 5.0 Anti-fungals 0 Injectables 0 International 15.0
Location Wise Break-Up	Location Wise Break-Up USA 55.57 Europe 19.66 Canada, Australia & New Zealand 4.22 India 3.68 Australia 0 Canada 0 Africa 0 LATAM 0 South America 0 North America 0 Asia 0 Rest of the World 0 Others 16.87	Location Wise Break-Up USA 18.0 Canada, Australia & New Zealand 0 Africa 6.0 Australia 0 Latin America 76.0 Asia 0 Europe 0 South America 0 India 0 North America 0 Rest of the World 0 Canada 0	Location Wise Break-Up USA 0 Canada, Australia & New Zealand 0 Africa 0.72 Australia 0.53 LATAM 0 Asia Pacific 4.5 Europe 3.67 South America 0.23 India 89.07 North America 1.27 Rest of the World 0 Canada 0 Others 0.01
Distribution Channel	Distribution Channel B2B 98.0 B2C 2.0 Tender Business 0 Pharmacy Sales 0 Distributors 0	Distribution Channel Pharmacy and Dietary 35.0 Tender Business 20.0 Distribution 45.0 B2C 0 B2B 0	-

Gland Pharma Ltd.

SIGN UP FOR FREE